BTAI - Financial Reports List - BioXcel Therapeutics, Inc. - IntrinsicAlpha

BioXcel Therapeutics, Inc. BTAI

Healthcare - Biotechnology - NASDAQ - US

$ 1.61

-1.72 %

$ 8.83 M

Market Cap

-0.07

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-2.66%	51.21%	46.81%
Annual Report	FY	10-K	2024-12-31	64.20%	66.71%	60.85%
Quarterly Report	Q3	8-K	2024-09-30	-37.24%	72.96%	68.34%
Quarterly Report	Q2	8-K	2024-06-30	141.58%	84.49%	69.36%
Quarterly Report	Q1	8-K	2024-03-31	182.52%	47.50%	53.26%
Quarterly Report	Q4	8-K	2023-12-31	57.98%	61.68%	62.70%
Annual Report	FY	10-K	2023-12-31	268.00%	-4.19%	-7.60%
Quarterly Report	Q3	8-K	2023-09-30	148.91%	-13.15%	-23.87%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-37.04%	-44.44%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-62.18%	-62.64%

1